Evidence map›Paper›PMID 32492066›Full record

ArticlePLoS pathogens2020

Tn-Seq reveals hidden complexity in the utilization of host-derived glutathione in Francisella tularensis.

Kathryn M Ramsey, Hannah E Ledvina, Tenayaann M Tresko, Jamie M Wandzilak, Catherine A Tower, Thomas Tallo, Caroline E Schramm, S Brook Peterson, Shawn J Skerrett, Joseph D Mougous and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Microbial metabolism of host-derived antioxidants.Current opinion in chemical biology · 2025
    Review
  4. Article
  5. Article
  6. Diverse roles of low-molecular weight thiol GSH inCurrent research in microbial sciences · 2024
    Article
  7. Tolfenpyrad displaysMicrobiology spectrum · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kathryn M RamseyDivision of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-9014-4416
Hannah E LedvinaDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, United States of America.ORCID 0000-0002-9631-5626
Tenayaann M TreskoDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, United States of America.ORCID 0000-0002-4541-9679
Jamie M WandzilakDepartments of Cell and Molecular Biology and Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, United States of America.
Catherine A TowerDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Thomas TalloDivision of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-6414-0542
Caroline E SchrammDivision of Pulmonary, Critical Care and Sleep Medicine, Harborview Medical Center, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0001-9576-7711
S Brook PetersonDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Shawn J SkerrettDivision of Pulmonary, Critical Care and Sleep Medicine, Harborview Medical Center, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-9622-4070
Joseph D MougousDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, United States of America.ORCID 0000-0002-5417-4861
Simon L DoveDivision of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0002-3758-608X
University of Washington · USBoston Children's Hospital · USHoward Hughes Medical Institute · USUniversity of Rhode Island · US

Funding

Identity, function and control of Francisella effectors encoded outside its pathogenicity islandR01AI145954 · NIAID · UNIVERSITY OF WASHINGTON · PI DOVE, SIMON L, MOUGOUS, JOSEPH DAVID · 2019 to 2023
$3.7M
Pediatric Infectious Diseases Research TrainingT32HD055148 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI WESSELS, MICHAEL R · 2008 to 2018
$2.7M
Control of virulence gene expression in Francisella tularensisR01AI081693 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI DOVE, SIMON L · 2010 to 2014
$2.1M
Control of virulence gene expression in Francisella tularensisR56AI081693 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI DOVE, SIMON L · 2018 to 2018
$489k
Human Alveolar Macrophage Interactions with Francisella tularensisR21AI130798 · NIAID · UNIVERSITY OF WASHINGTON · PI SKERRETT, SHAWN J. · 2018 to 2019
$468k
Azure Sapphire BioimagerS10OD026741 · OD · UNIVERSITY OF WASHINGTON · PI SMITH, JASON G · 2019 to 2019
$76k
NIAID NIH HHS R01 AI081693NIAID NIH HHS R01 AI145954NIAID NIH HHS R21 AI130798NIAID NIH HHS R56 AI081693NICHD NIH HHS T32 HD055148NIH HHS S10 OD026741
6 · The paper itself

Abstract

Host-derived glutathione (GSH) is an essential source of cysteine for the intracellular pathogen Francisella tularensis. In a comprehensive transposon insertion sequencing screen, we identified several F. tularensis genes that play central and previously unappreciated roles in the utilization of GSH during the growth of the bacterium in macrophages. We show that one of these, a gene we named dptA, encodes a proton-dependent oligopeptide transporter that enables growth of the organism on the dipeptide Cys-Gly, a key breakdown product of GSH generated by the enzyme γ-glutamyltranspeptidase (GGT). Although GGT was thought to be the principal enzyme involved in GSH breakdown in F. tularensis, our screen identified a second enzyme, referred to as ChaC, that is also involved in the utilization of exogenous GSH. However, unlike GGT and DptA, we show that the importance of ChaC in supporting intramacrophage growth extends beyond cysteine acquisition. Taken together, our findings provide a compendium of F. tularensis genes required for intracellular growth and identify new players in the metabolism of GSH that could be attractive targets for therapeutic intervention.

Indexed as

Bacterial ProteinsGlutathioneMacrophagesTransglutaminasesTularemiaAnimalsCell LineDipeptidesFemaleFrancisella tularensisHost-Pathogen InteractionsMiceBacterial ProteinscysteinylglycineDipeptidesGlutathioneTransglutaminases

Identifiers

PMID32492066
PMCPMC7340319
OpenAlexW3028613854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.